Search results

76 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Scientists awarded $2.4 million to study genetic variation in people with diabetes
The goal of the study is to identify genetic variations that may help predict the response to various treatment options for type 2 diabetes to reduce cardiovascular disease.
Located in News / 2012 / April
Join Dr. John Buse for live Facebook chat on diabetes
Dr. John Buse, director of the UNC Diabetes Care Center and chair of the National Diabetes Education Program, will host a live Facebook chat on diabetes management and prevention on Tuesday, May 22.
Located in News / 2012 / May
Antibodies reverse Type 1 diabetes in new immunotherapy study
Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease.
Located in News / 2012 / July
Three UNC specialties nationally ranked by U.S. News
Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.
Located in News / 2012 / July
Head-to-head trial of two diabetes drugs yields mixed results
Daily injections of liraglutide were slightly more effective than weekly injections of exenatide in lowering blood sugar and promoting weight loss. However, patients had fewer negative side effects on exenatide once weekly.
Located in News / 2012 / November
UNC's Dr. John Buse named to international diabetes prize selection jury
The 2013 Harold Hamm International Prize for Biomedical Research in Diabetes encourages research focused on progress toward a cure.
Located in News / 2012 / November
UNC study helps clarify link between high saturated fat diet and type 2 diabetes
New research from the University of North Carolina at Chapel Hill School of Medicine adds clarity to the connection. The study published on-line April 10th in the journal Nature Immunology finds that saturated fatty acids but not the unsaturated type can activate immune cells to produce an inflammatory protein, called interleukin-1beta.
Located in News / 2011 / April
UNC expert: Combining exenatide with insulin may be 'best result ever' for diabetes patients
A new study finds that combining the newer diabetes drug exenatide with insulin provides better blood sugar control in patients with type 2 diabetes than insulin alone and helps promote weight loss.
Located in News / 2010 / December
Treating pregnant women for mild gestational diabetes reduces serious birthing problems
Treating pregnant women for mild gestational diabetes resulted in fewer cesarean sections and other serious birthing problems associated with larger than average babies, according to a study conducted in part at the University of North Carolina at Chapel Hill.
Located in News / 2009 / September
Buse recognized as leading expert in type 2 diabetes
John B. Buse, MD, PhD, chief of the division of endocrinology and director of the Diabetes Care Center, has been ranked as one of the world’s foremost experts in type 2 diabetes based on an analysis of publications in the National Library of Medicine’s MEDLINE database.
Located in Vital Signs / 2014 / June 19